January 17, 2022
Bad Homburg, Germany
UniCredit Kepler Cheuvreux 21st German Corporate Conference - Virtual
January 17 – 18, 2022
January 12, 2022
Bad Homburg, Germany
Commerzbank and ODDO BHF German Investment Seminar
January 10, 2022 - 02:15 pm - 00:00 am
Bad Homburg, Germany
40th Annual J.P. Morgan Healthcare Conference - Virtual
January 10 – 11, 2022
The following charts describe the shareholder structure of Fresenius SE & Co. KGaA (as of December 31, 2025). The Else Kröner-Fresenius-Stiftung is the largest shareholder of Fresenius SE & Co. KGaA, with 27% of the shares. In addition, we received several notifications pursuant to the German Securities Trading Act (WpHG) as listed below.
Shareholder structure by investors
.
Shareholder structure institutional investors by region
Full text of the publications in accordance with Section 40 German Securities Trading Act (WpHG) (until January 2, 2018, in accordance with Section 26 WpHG) :
Related Links
Interactive ToolHere you will find the key figures for the Fresenius Group. Additional key financial figures are available at our interactive analysis tool, which can be used to process or analyze the figures in graphical form.
Key Credit Figures Fresenius Group (IFRS)
| 2024 | 2023 | 2022 | |
|---|---|---|---|
Net debt/EBITDA1,2,3 | 3.0 | 3.8 | 3.8 |
| |||
Debt (€m)1 | 13,577 | 15,830 | 14,708 |
Net debt (€m)1 | 11,295 | 13,268 | 13,316 |
| |||
Cash Conversion Rate1 | 1.0 | 1.0 | 0.9 |
EBITDA/Financial result1,3 | 8.3 | 8.4 | 13.8 |
-
1 The previous year’s figures were adjusted due to divestments and the deconsolidation of Fresenius Medical Care
2 Proforma closed acquisitions/divestitures, including lease liabilities, including Fresenius Medical Care dividend
3 Before special items
The Fresenius SE & Co. KGaA Commercial Paper Program enables Fresenius to issue short-term notes of up to €1.5 bn on the money market. The issuances are made through the European Commercial Paper Program (ECP).
Commercial Paper Program
| Issuer | Fresenius SE & Co. KGaA, Fresenius Finance Ireland plc. |
|---|---|
Program amount | € 1,500,000,000 |
Arranger | Commerzbank |
Dealer | Barclays, Commerzbank, Crédit Agricole, DZ BANK AG, Landesbank Baden-Württemberg, Landesbank Hessen-Thüringen, ING Bank N.V. |
Issuing and paying agent | Commerzbank |
Term | up to 1 year less 1 day |
Fresenius Kabi is investing about €35 million to modernize the company’s production facility in Louviers, France. Two sterilization units and two production lines for Freeflex® infusion bags will be housed in a 3,300-square-meter (35,500-square-foot) building being constructed on the site and will replace the existing production facilities. In this way, the company will continue to ensure the availability of these important products into the future. The modernization is scheduled for completion before the end of 2023. Fresenius Kabi employs some 370 people at the Louviers plant and has a total of about 1,500 employees in France.